# Topical and Local TXA in Facelifts - A Randomized Controlled Double Blinded Study

> **NCT06345833** · EARLY_PHASE1 · RECRUITING · sponsor: **University of Minnesota** · enrollment: 50 (estimated)

## Conditions studied

- Hemophilia
- Hemorrhage
- Facelift Surgery

## Interventions

- **DRUG:** 1%Tranexamic acid with standard local
- **DRUG:** 3% TXA
- **DRUG:** 1% TXA with local plus 3% TXA-soaked pledgets

## Key facts

- **NCT ID:** NCT06345833
- **Lead sponsor:** University of Minnesota
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-07-01
- **Primary completion:** 2026-07-01
- **Final completion:** 2026-07-01
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2025-08-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06345833

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06345833, "Topical and Local TXA in Facelifts - A Randomized Controlled Double Blinded Study". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06345833. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*